[Expert consensus post-marketing evaluation scheme to detect immunotoxicity of Chinese medicine in clinical populations (draft version for comments)].

Xie, Yan-Ming; Zhao, Yu-Bin; Jiang, Jun-Jie; Chang, Yan-Peng; Zhang, Wen; Shen, Hao; Lu, Peng-Fei

Xie, Yan-Ming; Zhao, Yu-Bin; Jiang, Jun-Jie; Chang, Yan-Peng; Zhang, Wen; Shen, Hao; Lu, Peng-Fei.

Affiliation

Xie YM; Institute of Basic Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing 100700, China.
Zhao YB; Institute of Basic Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing 100700, China.
Jiang JJ; Institute of Basic Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing 100700, China.
Chang YP; Institute of Basic Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing 100700, China.
Zhang W; Institute of Basic Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing 100700, China.
Shen H; Institute of Basic Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing 100700, China.
Lu PF; Institute of Basic Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing 100700, China.

Zhongguo Zhong Yao Za Zhi ; 38(18): 2933-6, 2013 Sep.

Article in Zh | MEDLINE | ID: mdl-24471307

Subject(s)

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Product Surveillance, Postmarketing / Drugs, Chinese Herbal / Immunologic Techniques / Drug Monitoring / Drug Hypersensitivity Type of study: Etiology_studies / Evaluation_studies / Guideline Limits: Humans Language: Zh Journal: Zhongguo Zhong Yao Za Zhi Journal subject: FARMACOLOGIA / TERAPIAS COMPLEMENTARES Year: 2013 Document type: Article Affiliation country: China

Search on Google

Add to My VHL

XML

PubMed Links